BiomX Inc. – AMEX:PHGE-WT

BiomX stock price today

$0.019
+0.00
+50.41%

BiomX stock price monthly change

+71.43%
month

BiomX key metrics

Market Cap
 N/A
Enterprise value
 N/A
P/E
 -4.09
EV/Sales
 N/A
EV/EBITDA
 -7.03
Price/Sales
 N/A
Price/Book
 0.01
PEG ratio
 0.04
EPS
 -0.52
Revenue
 -354K
EBITDA
 -17.65M
Income
 -29.61M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 4987.57%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BiomX stock price history

BiomX stock forecast

BiomX financial statements

Profit Margin

BiomX Inc. (AMEX:PHGE-WT): Profit margin
Jun 2023 -90K -6.41M 7123.33%
Sep 2023 -89K -382K 429.21%
Dec 2023 -87K -5.49M 6311.49%
Mar 2024 -88K -17.32M 19689.77%
PHGE-WT income statement history

Debt to Assets

BiomX Inc. (AMEX:PHGE-WT): Debt to assets
Jun 2023 41253000 25.38M 61.54%
Sep 2023 33056000 24.90M 75.33%
Dec 2023 58156000 55.07M 94.7%
Mar 2024 81606000 58.73M 71.97%
PHGE-WT balance sheet history

Cash Flow

BiomX Inc. (AMEX:PHGE-WT): Cash Flow
Jun 2023 -4.07M -1K 4.48M
Sep 2023 -5.92M -32K -1.30M
Dec 2023 -6.24M -6K -1.32M
Mar 2024 -11.35M 663K 38.97M
PHGE-WT cash flow history

BiomX other data

BiomX
Insider Trading

BiomX Inc. (AMEX:PHGE-WT): Insider trades (number of shares)
Period Buy Sel
Aug 2022 0 235159
Sep 2022 0 159429
Oct 2022 0 239016
Nov 2022 0 7217
Transaction Date Insider Security Shares Price per share Total value Source
Sale
UGWUMBA CHIDOZIE other
 Common Stock 1,501 $0.38 $567
Sale
UGWUMBA CHIDOZIE other
 Common Stock 2,000 $0.37 $732
Sale
UGWUMBA CHIDOZIE other
 Common Stock 2,416 $0.36 $867
Sale
UGWUMBA CHIDOZIE other
 Common Stock 1,300 $0.36 $473
Sale
UGWUMBA CHIDOZIE other
 Common Stock 3,300 $0.37 $1,224
Sale
UGWUMBA CHIDOZIE other
 Common Stock 1,526 $0.36 $543
Sale
UGWUMBA CHIDOZIE other
 Common Stock 1,505 $0.36 $548
Sale
UGWUMBA CHIDOZIE other
 Common Stock 12,500 $0.35 $4,325
Sale
UGWUMBA CHIDOZIE other
 Common Stock 3,072 $0.37 $1,121
Sale
UGWUMBA CHIDOZIE other
 Common Stock 5,900 $0.35 $2,059
PHGE-WT insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of BiomX stock today?

    One share of BiomX stock can currently be purchased for approximately $0.02.

  • When is BiomX's next earnings date?

    Unfortunately, BiomX's (PHGE-WT) next earnings date is currently unknown.

  • Does BiomX pay dividends?

    No, BiomX does not pay dividends.

  • What is BiomX's stock symbol?

    BiomX Inc. is traded on the AMEX under the ticker symbol "PHGE-WT".

  • What is BiomX's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of BiomX?

    Shares of BiomX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

BiomX company profile:

BiomX Inc.

Exchange:

AMEX

Full time employees:

0

Industry:

Biotechnology

Sector:

Healthcare

BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).


,

CIK: 0001739174
:
: